At 24 months, endocrine therapy appeared to have a more negative effect on HRQOL as measured by the global health status (GHS ...

New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...

Some early breast cancer patients can safely avoid certain surgeries. That's according to two studies published Thursday that ...

Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.

Outside experts say, however, that the choice of control group in the trial may limit the relevance to clinical practice.

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...

A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study suggests.

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer.

A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the ...

Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of ...

Several biomarkers may predict improved treatment responses and outcomes in patients with triple-negative breast cancer.